Nature structural & molecular biology, ISSN 1545-9993, 2013, Volume 20, Issue 7, pp. 796 - +
A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-infected donors recognize glycan-dependent epitopes on HIV-1...
SITE | COMPLEX | DOMAIN | NEUTRALIZING ANTIBODIES | RECOGNITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BROAD | CELL BIOLOGY | POTENT | EPITOPE | EVOLUTION | BIOPHYSICS | STRUCTURAL BASIS | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Antibodies, Neutralizing - metabolism | Molecular Sequence Data | Crystallography, X-Ray | Structure-Activity Relationship | Glycosylation - drug effects | HIV Envelope Protein gp120 - ultrastructure | Biopolymers | HIV Envelope Protein gp120 - metabolism | Antigen-Antibody Reactions | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Protein Processing, Post-Translational - drug effects | HEK293 Cells | 1-Deoxynojirimycin - analogs & derivatives | HIV Envelope Protein gp120 - chemistry | Carbohydrate Sequence | HIV Antibodies - metabolism | Amino Acid Sequence | CD4 Antigens - immunology | Alkaloids - pharmacology | Models, Molecular | Microscopy, Electron | HIV Antibodies - chemistry | Amino Acid Motifs | 1-Deoxynojirimycin - pharmacology | Polysaccharides - physiology | Antibodies, Neutralizing - chemistry | Protein Conformation | Epitopes - chemistry | Molecular Docking Simulation | Immunoglobulin Fab Fragments - immunology | Binding Sites, Antibody | CD4 Antigens - metabolism | Physiological aspects | Glycoproteins | Genetic aspects | Research | Structure | HIV (Viruses) | Health aspects | Antigenic determinants | Biomedical research | Molecular biology | Human immunodeficiency virus--HIV | Polyclonal antibodies | Medical immunity
SITE | COMPLEX | DOMAIN | NEUTRALIZING ANTIBODIES | RECOGNITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BROAD | CELL BIOLOGY | POTENT | EPITOPE | EVOLUTION | BIOPHYSICS | STRUCTURAL BASIS | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Antibodies, Neutralizing - metabolism | Molecular Sequence Data | Crystallography, X-Ray | Structure-Activity Relationship | Glycosylation - drug effects | HIV Envelope Protein gp120 - ultrastructure | Biopolymers | HIV Envelope Protein gp120 - metabolism | Antigen-Antibody Reactions | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Protein Processing, Post-Translational - drug effects | HEK293 Cells | 1-Deoxynojirimycin - analogs & derivatives | HIV Envelope Protein gp120 - chemistry | Carbohydrate Sequence | HIV Antibodies - metabolism | Amino Acid Sequence | CD4 Antigens - immunology | Alkaloids - pharmacology | Models, Molecular | Microscopy, Electron | HIV Antibodies - chemistry | Amino Acid Motifs | 1-Deoxynojirimycin - pharmacology | Polysaccharides - physiology | Antibodies, Neutralizing - chemistry | Protein Conformation | Epitopes - chemistry | Molecular Docking Simulation | Immunoglobulin Fab Fragments - immunology | Binding Sites, Antibody | CD4 Antigens - metabolism | Physiological aspects | Glycoproteins | Genetic aspects | Research | Structure | HIV (Viruses) | Health aspects | Antigenic determinants | Biomedical research | Molecular biology | Human immunodeficiency virus--HIV | Polyclonal antibodies | Medical immunity
Journal Article
Journal of Virology, ISSN 0022-538X, 05/2018, Volume 92, Issue 9
Adequate information on the precise molecular and biological composition of the viral strains that establish HIV infection in the human host will provide...
Transmitted founder virus | Coreceptor tropism | Human immunodeficiency virus | Amino acid diversity | Resistance to neutralization | Mother-to-child transmission | ANTIBODIES | POTENT NEUTRALIZATION | VARIANTS | resistance to neutralization | coreceptor tropism | amino acid diversity | VIROLOGY | transmitted founder virus | human immunodeficiency virus | RESISTANCE | INFECTION | DIVERSITY | MARAVIROC | TO-CHILD TRANSMISSION | TYPE-1 | CCR5 | mother-to-child transmission | Anti-HIV Agents - pharmacology | HIV Envelope Protein gp120 - genetics | Cell Line | CCR5 Receptor Antagonists - pharmacology | Antibodies, Monoclonal - pharmacology | Cyclohexanes - pharmacology | HIV Infections - virology | Humans | Receptors, CXCR6 - metabolism | Infant | HIV-1 - genetics | HIV-1 - classification | HIV Envelope Protein gp120 - immunology | Triazoles - pharmacology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Maraviroc | Virus Replication | HEK293 Cells | Adult | Antibodies, Viral - immunology | HIV Infections - drug therapy | Antibodies, Monoclonal - immunology | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Infectious Medicine | Klinisk medicin
Transmitted founder virus | Coreceptor tropism | Human immunodeficiency virus | Amino acid diversity | Resistance to neutralization | Mother-to-child transmission | ANTIBODIES | POTENT NEUTRALIZATION | VARIANTS | resistance to neutralization | coreceptor tropism | amino acid diversity | VIROLOGY | transmitted founder virus | human immunodeficiency virus | RESISTANCE | INFECTION | DIVERSITY | MARAVIROC | TO-CHILD TRANSMISSION | TYPE-1 | CCR5 | mother-to-child transmission | Anti-HIV Agents - pharmacology | HIV Envelope Protein gp120 - genetics | Cell Line | CCR5 Receptor Antagonists - pharmacology | Antibodies, Monoclonal - pharmacology | Cyclohexanes - pharmacology | HIV Infections - virology | Humans | Receptors, CXCR6 - metabolism | Infant | HIV-1 - genetics | HIV-1 - classification | HIV Envelope Protein gp120 - immunology | Triazoles - pharmacology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Maraviroc | Virus Replication | HEK293 Cells | Adult | Antibodies, Viral - immunology | HIV Infections - drug therapy | Antibodies, Monoclonal - immunology | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Infectious Medicine | Klinisk medicin
Journal Article
Journal of Molecular Biology, ISSN 0022-2836, 04/2017, Volume 429, Issue 7, pp. 930 - 947
Direct calculation of relative binding affinities between antibodies and antigens is a long-sought goal. However, despite substantial efforts, no generally...
alchemical FEP | physics-based models | computational chemistry | binding affinity optimization | protein structure prediction | REFINEMENT | CD4-BINDING SITE | LOOP PREDICTION | POTENCY | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENVELOPE | INFECTION | OPTIMIZATION | GLYCOSYLATION | SIMULATIONS | RATIONAL DESIGN | HIV Antibodies - metabolism | Surface Plasmon Resonance | Thermodynamics | Antibodies, Neutralizing - chemistry | Antibodies, Neutralizing - metabolism | Computational Biology | Protein Binding | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - chemistry | HIV Envelope Protein gp120 - metabolism | Viral antibodies | Antibodies | Analysis | Protein-protein interactions | Protein binding | Molecular dynamics | Protein structure prediction | HIV (Viruses) | REST, replica exchange solute tempering | FEP, free energy perturbation | RSC3, resurfaced stabilized core 3 | PB, Poisson–Boltzmann | MD, molecular dynamics | GPU, graphics processing unit | bNAbs, broadly neutralizing antibodies | PDB, protein data bank | CDR H2, second heavy chain complementarity-determining region | RMSE, RMS error
alchemical FEP | physics-based models | computational chemistry | binding affinity optimization | protein structure prediction | REFINEMENT | CD4-BINDING SITE | LOOP PREDICTION | POTENCY | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENVELOPE | INFECTION | OPTIMIZATION | GLYCOSYLATION | SIMULATIONS | RATIONAL DESIGN | HIV Antibodies - metabolism | Surface Plasmon Resonance | Thermodynamics | Antibodies, Neutralizing - chemistry | Antibodies, Neutralizing - metabolism | Computational Biology | Protein Binding | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - chemistry | HIV Envelope Protein gp120 - metabolism | Viral antibodies | Antibodies | Analysis | Protein-protein interactions | Protein binding | Molecular dynamics | Protein structure prediction | HIV (Viruses) | REST, replica exchange solute tempering | FEP, free energy perturbation | RSC3, resurfaced stabilized core 3 | PB, Poisson–Boltzmann | MD, molecular dynamics | GPU, graphics processing unit | bNAbs, broadly neutralizing antibodies | PDB, protein data bank | CDR H2, second heavy chain complementarity-determining region | RMSE, RMS error
Journal Article
Journal of Virology, ISSN 0022-538X, 07/2002, Volume 76, Issue 14, pp. 7293 - 7305
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
C-TYPE LECTINS | CD4 RECEPTOR | VIROLOGY | EXTERIOR ENVELOPE GLYCOPROTEIN | CYANOVIRIN-N | STRUCTURAL BASIS | DC-SIGN | SURFACE GLYCOPROTEIN | HUMORAL IMMUNITY | HUMAN MONOCLONAL-ANTIBODIES | HIV GP120 | Carbohydrate Sequence | HIV Envelope Protein gp120 - genetics | Epitope Mapping | Humans | Models, Molecular | Molecular Sequence Data | Neutralization Tests | Glycosylation | Sequence Analysis, DNA | HIV Envelope Protein gp120 - immunology | Mannose - metabolism | HIV-1 - immunology | HIV Antibodies - immunology | Glycoside Hydrolases - metabolism | HIV Envelope Protein gp120 - chemistry | Antibodies, Monoclonal - immunology | Mannose - chemistry | Pathogenesis and Immunity
C-TYPE LECTINS | CD4 RECEPTOR | VIROLOGY | EXTERIOR ENVELOPE GLYCOPROTEIN | CYANOVIRIN-N | STRUCTURAL BASIS | DC-SIGN | SURFACE GLYCOPROTEIN | HUMORAL IMMUNITY | HUMAN MONOCLONAL-ANTIBODIES | HIV GP120 | Carbohydrate Sequence | HIV Envelope Protein gp120 - genetics | Epitope Mapping | Humans | Models, Molecular | Molecular Sequence Data | Neutralization Tests | Glycosylation | Sequence Analysis, DNA | HIV Envelope Protein gp120 - immunology | Mannose - metabolism | HIV-1 - immunology | HIV Antibodies - immunology | Glycoside Hydrolases - metabolism | HIV Envelope Protein gp120 - chemistry | Antibodies, Monoclonal - immunology | Mannose - chemistry | Pathogenesis and Immunity
Journal Article
BBA - General Subjects, ISSN 0304-4165, 08/2018, Volume 1862, Issue 8, pp. 1790 - 1800
HIV infection and/or the direct pathogenic effects of circulating HIV proteins impairs the physiological function of mesenchymal stem cells (MSCs), and...
gp120 | CXCR4 | HIV | Cell migration | Focal adhesion kinase (FAK) | Mesenchymal stem cells | TYROSINE PHOSPHORYLATION | GENOMIC ORGANIZATION | CHEMOKINE RECEPTOR CXCR4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | BONE-MARROW | ENVELOPE GLYCOPROTEIN | HEMATOPOIETIC PROGENITOR CELLS | FOCAL ADHESION PROTEINS | BIOPHYSICS | IMMUNODEFICIENCY-VIRUS TYPE-1 | STROMAL CELLS | T-CELLS | Viral proteins | Comorbidity | Stem cells | Physiological aspects | T cells | HIV (Viruses) | Muscle proteins | HIV infection
gp120 | CXCR4 | HIV | Cell migration | Focal adhesion kinase (FAK) | Mesenchymal stem cells | TYROSINE PHOSPHORYLATION | GENOMIC ORGANIZATION | CHEMOKINE RECEPTOR CXCR4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | BONE-MARROW | ENVELOPE GLYCOPROTEIN | HEMATOPOIETIC PROGENITOR CELLS | FOCAL ADHESION PROTEINS | BIOPHYSICS | IMMUNODEFICIENCY-VIRUS TYPE-1 | STROMAL CELLS | T-CELLS | Viral proteins | Comorbidity | Stem cells | Physiological aspects | T cells | HIV (Viruses) | Muscle proteins | HIV infection
Journal Article
6.
Full Text
Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e52170
HIV envelope glycoproteins undergo large-scale conformational changes as they interact with cellular receptors to cause the fusion of viral and cellular...
CCR5 BINDING | FLUCTUATION DYNAMICS | CD4 RECEPTOR | PROTEIN SECONDARY STRUCTURE | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4-BOUND STATE | FORCE-FIELD | ATOM MOLECULAR-MECHANICS | NORMAL-MODE | RECEPTOR-BINDING | Humans | Models, Molecular | Antibodies, Neutralizing - pharmacology | HIV Antibodies - chemistry | HIV Envelope Protein gp120 - metabolism | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Computer Simulation | Protein Binding | Protein Conformation | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | CD4 Antigens - metabolism | Viral antibodies | Analysis | Crystals | Antibodies | Glycoproteins | HIV (Viruses) | Structure | Protein binding | Pictures | Membranes | Biochemistry | Biopolymers | Fragmentation | Proteins | Receptors | Network analysis | Human immunodeficiency virus--HIV | Plasticity | Masking | Elastic analysis | Crystal structure | Immune system | Enzymes | Structural members | Computer simulation | Deformation mechanisms | Glycoprotein | Fragments | Biophysics | Epitopes | CD4 antigen | Virology | Simulation | Computation | Computer applications | Plastic properties | Glycoprotein gp120 | Binding sites | Neutralization | HIV | Human immunodeficiency virus
CCR5 BINDING | FLUCTUATION DYNAMICS | CD4 RECEPTOR | PROTEIN SECONDARY STRUCTURE | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4-BOUND STATE | FORCE-FIELD | ATOM MOLECULAR-MECHANICS | NORMAL-MODE | RECEPTOR-BINDING | Humans | Models, Molecular | Antibodies, Neutralizing - pharmacology | HIV Antibodies - chemistry | HIV Envelope Protein gp120 - metabolism | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Computer Simulation | Protein Binding | Protein Conformation | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | CD4 Antigens - metabolism | Viral antibodies | Analysis | Crystals | Antibodies | Glycoproteins | HIV (Viruses) | Structure | Protein binding | Pictures | Membranes | Biochemistry | Biopolymers | Fragmentation | Proteins | Receptors | Network analysis | Human immunodeficiency virus--HIV | Plasticity | Masking | Elastic analysis | Crystal structure | Immune system | Enzymes | Structural members | Computer simulation | Deformation mechanisms | Glycoprotein | Fragments | Biophysics | Epitopes | CD4 antigen | Virology | Simulation | Computation | Computer applications | Plastic properties | Glycoprotein gp120 | Binding sites | Neutralization | HIV | Human immunodeficiency virus
Journal Article
Journal of Virology, ISSN 0022-538X, 01/2013, Volume 87, Issue 2, pp. 923 - 934
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
SUBTYPE-C | ATOMIC-STRUCTURE | ENTRY INHIBITORS | VIROLOGY | SMALL-MOLECULE | CORECEPTOR USAGE | CCR5 ANTAGONISTS | DRUG-RESISTANCE | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | REPLICATIVE FITNESS | Anti-HIV Agents - pharmacology | HIV Envelope Protein gp120 - genetics | HIV-1 - drug effects | Cyclohexanes - pharmacology | Humans | Drug Resistance, Viral | Molecular Sequence Data | Mutation, Missense | HIV-1 - genetics | Sequence Analysis, DNA | Microbial Sensitivity Tests | Triazoles - pharmacology | DNA Mutational Analysis | HIV-1 - isolation & purification | Virus Cultivation | Serial Passage | Vaccines and Antiviral Agents
SUBTYPE-C | ATOMIC-STRUCTURE | ENTRY INHIBITORS | VIROLOGY | SMALL-MOLECULE | CORECEPTOR USAGE | CCR5 ANTAGONISTS | DRUG-RESISTANCE | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | REPLICATIVE FITNESS | Anti-HIV Agents - pharmacology | HIV Envelope Protein gp120 - genetics | HIV-1 - drug effects | Cyclohexanes - pharmacology | Humans | Drug Resistance, Viral | Molecular Sequence Data | Mutation, Missense | HIV-1 - genetics | Sequence Analysis, DNA | Microbial Sensitivity Tests | Triazoles - pharmacology | DNA Mutational Analysis | HIV-1 - isolation & purification | Virus Cultivation | Serial Passage | Vaccines and Antiviral Agents
Journal Article
PLoS Pathogens, ISSN 1553-7366, 03/2015, Volume 11, Issue 3, pp. 1 - 33
The HIV-1 envelope glycoprotein, gp120, undergoes multiple molecular interactions and structural rearrangements during the course of host cell attachment and...
TYPE-1 GP120 | MEDIATED CYTOTOXICITY | CD4 BINDING-SITE | NEUTRALIZING ANTIBODY | HUMAN MONOCLONAL-ANTIBODY | MICROBIOLOGY | DEPENDENT CELLULAR CYTOTOXICITY | HIV-1 GP120 | VIROLOGY | VIRAL MEMBRANE-FUSION | CROSS-LINKED COMPLEXES | VACCINE EFFICACY TRIAL | PARASITOLOGY | HIV Envelope Protein gp120 - genetics | Virion - immunology | Humans | Receptors, CCR5 - genetics | Virion - genetics | Virion - chemistry | Epitopes - genetics | HIV-1 - genetics | Receptors, CCR5 - immunology | Viral Tropism - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | HIV Antigens - genetics | HIV Antigens - immunology | HIV-1 - chemistry | Receptors, CCR5 - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | HeLa Cells | Viral Tropism - genetics | Host-virus relationships | Viral proteins | HIV (Viruses) | Health aspects | Identification and classification | Antigenic determinants | Proteins | Infections | Human immunodeficiency virus | HIV | Experiments
TYPE-1 GP120 | MEDIATED CYTOTOXICITY | CD4 BINDING-SITE | NEUTRALIZING ANTIBODY | HUMAN MONOCLONAL-ANTIBODY | MICROBIOLOGY | DEPENDENT CELLULAR CYTOTOXICITY | HIV-1 GP120 | VIROLOGY | VIRAL MEMBRANE-FUSION | CROSS-LINKED COMPLEXES | VACCINE EFFICACY TRIAL | PARASITOLOGY | HIV Envelope Protein gp120 - genetics | Virion - immunology | Humans | Receptors, CCR5 - genetics | Virion - genetics | Virion - chemistry | Epitopes - genetics | HIV-1 - genetics | Receptors, CCR5 - immunology | Viral Tropism - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | HIV Antigens - genetics | HIV Antigens - immunology | HIV-1 - chemistry | Receptors, CCR5 - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | HeLa Cells | Viral Tropism - genetics | Host-virus relationships | Viral proteins | HIV (Viruses) | Health aspects | Identification and classification | Antigenic determinants | Proteins | Infections | Human immunodeficiency virus | HIV | Experiments
Journal Article
Journal of Molecular Biology, ISSN 0022-2836, 2011, Volume 410, Issue 5, pp. 798 - 810
After three decades of research, an effective vaccine against the pandemic AIDS caused by human immunodeficiency virus (HIV) is not still available, and a...
2G12/gp120 inhibition | high-mannose-type oligosaccharides | multivalent gold glyconanoparticles | NMR spectroscopy | surface plasmon resonance | Molecular Biology | LIGAND-BINDING | BIOCHEMISTRY & MOLECULAR BIOLOGY | VACCINE | FUSION INHIBITOR T-20 | TRANS-INFECTION | OLIGOSACCHARIDE | TRANSFER DIFFERENCE NMR | DC-SIGN | IMMUNODEFICIENCY-VIRUS TYPE-1 | GLYCONANOPARTICLES | TOOLS | Gold - chemistry | Surface Plasmon Resonance | Magnetic Resonance Spectroscopy | Humans | Metal Nanoparticles - chemistry | Neutralization Tests | Molecular Mimicry - immunology | Carbohydrates - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | HIV-1 - immunology | Oligosaccharides - chemistry | Oligosaccharides - immunology | Protein Binding | Titrimetry | HeLa Cells | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Nanoparticles | AIDS vaccines | Physiological aspects | Monoclonal antibodies | Nuclear magnetic resonance spectroscopy | Health aspects | Antigenic determinants
2G12/gp120 inhibition | high-mannose-type oligosaccharides | multivalent gold glyconanoparticles | NMR spectroscopy | surface plasmon resonance | Molecular Biology | LIGAND-BINDING | BIOCHEMISTRY & MOLECULAR BIOLOGY | VACCINE | FUSION INHIBITOR T-20 | TRANS-INFECTION | OLIGOSACCHARIDE | TRANSFER DIFFERENCE NMR | DC-SIGN | IMMUNODEFICIENCY-VIRUS TYPE-1 | GLYCONANOPARTICLES | TOOLS | Gold - chemistry | Surface Plasmon Resonance | Magnetic Resonance Spectroscopy | Humans | Metal Nanoparticles - chemistry | Neutralization Tests | Molecular Mimicry - immunology | Carbohydrates - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | HIV-1 - immunology | Oligosaccharides - chemistry | Oligosaccharides - immunology | Protein Binding | Titrimetry | HeLa Cells | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Nanoparticles | AIDS vaccines | Physiological aspects | Monoclonal antibodies | Nuclear magnetic resonance spectroscopy | Health aspects | Antigenic determinants
Journal Article
Scientific Reports, ISSN 2045-2322, 09/2016, Volume 6, Issue 1, pp. 33378 - 33378
The mechanisms behind HIV-1-associated neurocognitive disorders are still unclear. Apoptosis-stimulating protein 2 of p53 (ASPP2) is a damage-inducible...
PROGRAMMED CELL-DEATH | ACTIVATION | INDUCED APOPTOSIS | DNA | MULTIDISCIPLINARY SCIENCES | AGONISTS PROVIDE NEUROPROTECTION | CENTRAL-NERVOUS-SYSTEM | NEUROCOGNITIVE DISORDERS | NEUROPATHOGENESIS | EXPRESSION | P53 | Neurons - pathology | Transcription, Genetic - drug effects | Neurotoxicity Syndromes - genetics | Caspase 3 - metabolism | Cerebral Cortex - pathology | Protein Transport - drug effects | Cell Nucleus - metabolism | Neurotoxicity Syndromes - pathology | Time Factors | Protein Binding - drug effects | Neurons - metabolism | Cell Death - drug effects | Neurons - drug effects | HIV Envelope Protein gp120 - toxicity | bcl-2-Associated X Protein - genetics | Tumor Suppressor Proteins - metabolism | Cells, Cultured | Tumor Suppressor Protein p53 - metabolism | bcl-2-Associated X Protein - metabolism | Genotype | Mice, Knockout | Animals | Mice | Mice, Inbred BALB C | Cell Nucleus - drug effects | RNA, Small Interfering - metabolism | Cell culture | Cell survival | Bax protein | Transcription | Neurodegenerative diseases | p53 Protein | Cortex | Caspase | Retina | Cognition | siRNA | Caspase-3 | Proteins | Retinal ganglion cells | Neurotoxicity | Cell death | Rodents | Cell cycle | Alzheimers disease | Ganglion cells | Alzheimer's disease | Glycoprotein gp120 | Apoptosis | Index Medicus
PROGRAMMED CELL-DEATH | ACTIVATION | INDUCED APOPTOSIS | DNA | MULTIDISCIPLINARY SCIENCES | AGONISTS PROVIDE NEUROPROTECTION | CENTRAL-NERVOUS-SYSTEM | NEUROCOGNITIVE DISORDERS | NEUROPATHOGENESIS | EXPRESSION | P53 | Neurons - pathology | Transcription, Genetic - drug effects | Neurotoxicity Syndromes - genetics | Caspase 3 - metabolism | Cerebral Cortex - pathology | Protein Transport - drug effects | Cell Nucleus - metabolism | Neurotoxicity Syndromes - pathology | Time Factors | Protein Binding - drug effects | Neurons - metabolism | Cell Death - drug effects | Neurons - drug effects | HIV Envelope Protein gp120 - toxicity | bcl-2-Associated X Protein - genetics | Tumor Suppressor Proteins - metabolism | Cells, Cultured | Tumor Suppressor Protein p53 - metabolism | bcl-2-Associated X Protein - metabolism | Genotype | Mice, Knockout | Animals | Mice | Mice, Inbred BALB C | Cell Nucleus - drug effects | RNA, Small Interfering - metabolism | Cell culture | Cell survival | Bax protein | Transcription | Neurodegenerative diseases | p53 Protein | Cortex | Caspase | Retina | Cognition | siRNA | Caspase-3 | Proteins | Retinal ganglion cells | Neurotoxicity | Cell death | Rodents | Cell cycle | Alzheimers disease | Ganglion cells | Alzheimer's disease | Glycoprotein gp120 | Apoptosis | Index Medicus
Journal Article